Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.6.0.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Gentris Corporation
Gentris Corporation
Common Stock
Gentris Corporation
Additional Paid-in Capital
BioServe
BioServe
Common Stock
BioServe
Additional Paid-in Capital
Employee
Employee
Common Stock
Employee
Additional Paid-in Capital
Non-Employee
Non-Employee
Common Stock
Non-Employee
Additional Paid-in Capital
2015 Offering
2015 Offering
Common Stock
2015 Offering
Additional Paid-in Capital
2016 Offering
2016 Offering
Common Stock
2016 Offering
Additional Paid-in Capital
Beginning Balance (shares) at Dec. 31, 2014   9,821,000                                        
Beginning Balance at Dec. 31, 2014 $ 34,554 $ 1 $ 112,520 $ (77,967)                                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Stock based compensation (shares)                       35,000     0              
Stock based compensation                     $ 2,558   $ 2,558 $ 276   $ 276            
Exercise of warrants (shares)   0                                        
Exercise of warrants $ 1   1                                      
Exercise of options (shares) 4,000 4,000                                        
Exercise of options $ 23   23                                      
Issuance of common stock (shares)           3,000     789,000                 3,000,000        
Issuance of common stock         $ 34   $ 34 $ 5,436   $ 5,436             $ 10,319   $ 10,319      
Net loss (20,184)     (20,184)                                    
Ending Balance (shares) at Dec. 31, 2015   13,652,000                                        
Ending Balance at Dec. 31, 2015 $ 33,017 $ 1 131,167 (98,151)                                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Stock based compensation (shares)                       16,000                    
Stock based compensation                     $ 1,978   $ 1,978 $ 38   $ 38            
Exercise of options (shares) 0                                          
Issuance of common stock (shares)   50,000                                     5,218,000  
Issuance of common stock $ 75   75                                 $ 6,319 $ 1 $ 6,318
Net loss (15,803)     (15,803)                                    
Ending Balance (shares) at Dec. 31, 2016   18,936,000                                        
Ending Balance at Dec. 31, 2016 $ 25,624 $ 2 $ 139,576 $ (113,954)